Centre Directs States to Restrict Stem Cell Therapy for Autism to Approved Trials
The Union Health Ministry has directed States and Union Territories to restrict stem cell therapy to approved clinical trials for Autism Spectrum Disorder (ASD), emphasizing that such treatments should not be offered as routine clinical care. This follows a Supreme Court judgment and existing guidelines from the Indian Council of Medical Research. The Ministry also urged action against clinics and doctors offering unproven stem cell therapies for conditions not approved by the Ministry, with penalties applicable under medical and clinical establishment regulations in states adopting the relevant laws.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (50/100). Lens Score 62/100.
Outlets measured: thehindu, indianexpress. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (50–50/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
indianexpress broke this story on 17 Sept, 06:27 am. Other outlets followed.